TNXPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Tonix Pharmaceuticals Holding Corp.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$5.73−0.31 (-5.13%)
Close on Oct 19, 2026
- Market cap
- $95.32M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
54.6%
9M of 17M shares
Institutional holders
102
28 new, 5 sold out
Net institutional buying
5M
In Q2 2026
Insider trades, 12 months
7 buys · 0 sales
Net bought $458.76K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Millennium Management LLC | 890,366 | 5.60% | 13G (passive) | Jun 9, 2026 |
| AQR Capital Management Holdings, LLC | 882,595 | 5.54% | 13G (passive) | Jun 30, 2026 |
| BlackRock, Inc. | 854,579 | 6.70% | 13G (passive) amendment | Dec 31, 2025 |
| Sirenia Capital Management LP | 1,297,470 | 8.80% | 13G (passive) | Mar 31, 2026 |
| Point72 Asset Management, L.P. | 1,235,058 | 9.20% | 13G (passive) | Dec 29, 2025 |
| Point72 Capital Advisors, Inc. | 1,100,964 | 6.90% | 13G (passive) amendment | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of TNXP | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 1,398,041 | 8.15% | $17.84M | +429,864 | 0.00% |
| Point72 Asset Management, L.P. | 1,166,752 | 6.80% | $14.89M | +1,041,338 | 0.02% |
| Millennium Management LLC | 966,932 | 5.64% | $12.34M | +747,259 | 0.00% |
| Aqr Capital Management LLC | 882,595 | 5.15% | $11.26M | +721,387 | 0.00% |
| Vanguard Capital Management LLC | 691,895 | 4.03% | $8.83M | +173,245 | 0.00% |
| Jones Hill Capital LP | 625,428 | 3.65% | $7.98M | +173,312 | 1.70% |
| Geode Capital Management, LLC | 395,260 | 2.30% | $5.04M | +81,969 | 0.00% |
| Ishara Investments LP | 338,250 | 1.97% | $4.32M | New | 3.17% |
| State Street Corp | 271,374 | 1.58% | $3.46M | +40,767 | 0.00% |
| UBS Group AG | 231,682 | 1.35% | $2.96M | +4 | 0.00% |
| Citadel Advisors LLC | 195,859 | 1.14% | $2.50M | −272,853 | 0.00% |
| Essex Investment Management Co LLC | 165,144 | 0.96% | $2.11M | New | 0.28% |
| Balyasny Asset Management L.P. | 132,591 | 0.77% | $1.69M | −180,491 | 0.00% |
| Northern Trust Corp | 120,386 | 0.70% | $1.54M | +20,252 | 0.00% |
| Nuveen, LLC | 117,447 | 0.68% | $1.50M | +22,886 | 0.00% |
| Vanguard Fiduciary Trust Co | 102,054 | 0.60% | $1.30M | +17,784 | 0.00% |
| Goldman Sachs Group Inc | 98,356 | 0.57% | $1.26M | +45,301 | 0.00% |
| Vanguard Portfolio Management LLC | 97,954 | 0.57% | $1.25M | +19,327 | 0.00% |
| FMR LLC | 93,551 | 0.55% | $1.19M | +91,813 | 0.00% |
| Ieq Capital, LLC | 92,373 | 0.54% | $1.18M | +78,015 | 0.01% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 102 | 9M | 54.6% | 28 / 51 | 8 / 5 | 5M | 0M |
| Q1 2026 | 81 | 5M | 28.4% | 20 / 31 | 16 / 8 | 3M | 1M |
| Q4 2025 | 70 | 4M | 21.8% | 17 / 34 | 9 / 7 | 2M | 0M |
| Q3 2025 | 60 | 2M | 13.8% | 18 / 23 | 9 / 5 | 1M | 0M |
| Q2 2025 | 47 | 1M | 8.1% | 27 / 10 | 6 / 5 | 1M | 0M |
| Q1 2025 | 25 | 0M | 2.8% | 24 / 0 | 1 / 1 | 0M | 0M |
| Q4 2024 | 2 | 0M | 0.0% | 2 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of TNXP | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 488,108 | 2.85% | $6.23M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 389,931 | 2.27% | $4.98M | 0.01% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 187,414 | 1.09% | $2.39M | 0.00% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 158,829 | 0.93% | $1.59M | 0.00% | Jul 31, 2026 |
| iShares Russell 2000 Value ETF | 145,820 | 0.85% | $1.86M | 0.01% | Jun 30, 2026 |
| Fidelity Enhanced Small Cap Core ETF | 78,342 | 0.46% | $999.64K | 0.02% | Jun 30, 2026 |
| 1290 Essex Small Cap Growth Fund | 73,840 | 0.43% | $739.14K | 0.64% | Jul 31, 2026 |
| Vanguard Russell 2000 Index Fund | 69,338 | 0.40% | $854.94K | 0.00% | May 31, 2026 |
| College Retirement Equities Fund - Total Global Stock Account | 54,920 | 0.32% | $700.78K | 0.00% | Jun 30, 2026 |
| iShares Micro-Cap ETF | 49,085 | 0.29% | $626.32K | 0.04% | Jun 30, 2026 |
| Schwab Small-Cap Index Fund | 36,301 | 0.21% | $363.37K | 0.00% | Jul 31, 2026 |
| Fidelity Extended Market Index Fund | 35,565 | 0.21% | $438.52K | 0.00% | May 31, 2026 |
| Nuveen Equity Index Fund | 31,079 | 0.18% | $311.10K | 0.00% | Jul 31, 2026 |
| Master Small Cap Index Series | 29,354 | 0.17% | $374.56K | 0.01% | Jun 30, 2026 |
| AQR Small Cap Multi-Style Fund | 22,648 | 0.13% | $288.99K | 0.08% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Seth Lederman | Chief Executive Officer, Director | 31,007 | 0.18% | Aug 31, 2026 |
| Thomas Englese | Chief Commercial Officer | 694 | 0.00% | Sep 8, 2026 |
| Bradley Saenger | Chief Financial Officer | 2,154 | 0.01% | Jul 9, 2026 |
| Siobhan Fogarty | Chief Technology Officer | 1 | 0.00% | Feb 26, 2026 |
| Gregory M. Sullivan | Chief Medical Officer | 0 | – | Feb 26, 2026 |
| Jessica Edgar Morris | Chief Operating Officer | 0 | – | Feb 26, 2026 |
| Richard H. Bagger | Director | 1,000 | 0.01% | Aug 24, 2026 |
| Carolyn E. Taylor | Director | 1,833 | 0.01% | Jun 15, 2026 |
| Richard Newcomb Stillwell | Director | 5,000 | 0.03% | Jun 9, 2026 |
| James Randolph Hunter Jr | Director | – | – | May 14, 2026 |
| Adeoye Y. Olukotun | Director | 0 | – | May 14, 2026 |
| Margaret Smith Bell | Director | 0 | – | May 14, 2026 |
| David L. Grange | Director | – | – | May 14, 2026 |
| James Treco | Director | 250 | 0.00% | May 14, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Seth Lederman Chief Executive Officer, Director | Aug 27, 2026 | Buy | +2,000 | $13.79 | $27.58K | 11,005 |
| Richard H. Bagger Director | Aug 20, 2026 | Buy | +1,000 | $12.60 | $12.60K | 1,000 |
| Bradley Saenger Chief Financial Officer | Jun 30, 2026 | Other | +1,453 | $10.91 | $15.85K | 2,154 |
| Carolyn E. Taylor Director | Jun 12, 2026 | Buy | +1,415 | $10.55 | $14.93K | 1,833 |
| Seth Lederman Chief Executive Officer, Director | Jun 9, 2026 | Buy | +5,000 | $11.79 | $58.95K | 9,005 |
| Richard Newcomb Stillwell Director | Jun 8, 2026 | Buy | +5,000 | $11.65 | $58.25K | 5,000 |
| Seth Lederman Chief Executive Officer, Director | Mar 31, 2026 | Buy | +5,000 | $12.62 | $63.10K | 20,001 |
| Seth Lederman Chief Executive Officer, Director | Mar 18, 2026 | Buy | +15,000 | $14.89 | $223.35K | 15,001 |
| Bradley Saenger Chief Financial Officer, 10% owner | Dec 31, 2025 | Award | +701 | $13.42 | $9.41K | 701 |
| Carolyn E. Taylor Director | Aug 21, 2025 | Buy | +418 | $36.03 | $15.06K | 418 |
| James Treco Director | Aug 20, 2025 | Buy | +250 | $36.00 | $9.00K | 250 |
| Seth Lederman Chief Executive Officer, Director | May 15, 2025 | Buy | +4,000 | $21.55 | $86.20K | 4,005 |
| Margaret Smith Bell Director | Feb 5, 2025 | Other | −1 | $0.15 | $0 | 0 |
| James Treco Director | Feb 5, 2025 | Other | −0.02 | $0.30 | $0 | 0 |
| Richard H. Bagger Director | Feb 5, 2025 | Other | −0.02 | $0.20 | $0 | 0 |
| Gregory M. Sullivan Chief Medical Officer | Feb 5, 2025 | Other | −0.11 | $1.47 | $0 | 0 |
| Jessica Edgar Morris Chief Operating Officer | Feb 5, 2025 | Other | −1 | – | – | 0 |
| Bradley Saenger Chief Financial Officer | Feb 5, 2025 | Other | −0.04 | – | – | 0 |
| Seth Lederman Chief Executive Officer, Director | Feb 5, 2025 | Other | −0.22 | $3.30 | $1 | 1 |
| Seth Lederman Chief Executive Officer, Director | Feb 5, 2025 | Other | −5.18 | $3.38 | $18 | 5 |
| Seth Lederman Chief Executive Officer, Director | Feb 5, 2025 | Other | −1 | $0.15 | $0 | 0 |
| Adeoye Y. Olukotun Director | Jun 10, 2024 | Other | −0.81 | $1.91 | $2 | 0 |
| Seth Lederman Chief Executive Officer, Director | Jun 29, 2022 | Buy | +20,000 | $1.71 | $34.20K | 24,235 |
| Seth Lederman Chief Executive Officer, Director | Mar 25, 2022 | Buy | +100,000 | $0.25 | $25.00K | 112,177 |
| Seth Lederman Chief Executive Officer, Director | Sep 28, 2021 | Buy | +12,000 | $0.61 | $7.32K | 12,177 |
| Bradley Saenger Chief Financial Officer | Jun 30, 2021 | Award | +18,248 | $0.58 | $10.58K | 19,645 |
| Gregory M. Sullivan Chief Medical Officer | Jun 30, 2021 | Award | +36,496 | $0.58 | $21.17K | 99,223 |
| Daniel Wintner Goodman Director | May 25, 2021 | Buy | +5,000 | $1.12 | $5.60K | 5,001 |
| Seth Lederman Chief Executive Officer, Director | Mar 24, 2021 | Buy | +16,733 | $1.32 | $22.09K | 135,000 |
| Gregory M. Sullivan Chief Medical Officer | Jan 7, 2021 | Award | +41,322 | $0.51 | $21.07K | 62,727 |
| Seth Lederman Chief Executive Officer, Director | Dec 30, 2020 | Buy | +35,000 | $0.68 | $23.80K | 118,267 |
| James Treco Director | Aug 31, 2020 | Buy | +5,500 | $0.89 | $4.90K | 10,000 |
| Margaret Smith Bell Director | Aug 20, 2020 | Buy | +5,391 | $0.93 | $5.01K | 5,391 |
| Gregory M. Sullivan Chief Medical Officer | Aug 17, 2020 | Buy | +20,000 | $1.03 | $20.60K | 21,405 |
| James Treco Director | Aug 14, 2020 | Buy | +4,500 | $1.06 | $4.77K | 4,500 |
| Adeoye Y. Olukotun Director | Aug 13, 2020 | Buy | +5,350 | $0.94 | $5.03K | 5,350 |
| Richard H. Bagger Director | Aug 13, 2020 | Buy | +10,000 | $0.91 | $9.10K | 10,000 |
| Seth Lederman Chief Executive Officer, Director | Aug 13, 2020 | Buy | +60,000 | $0.91 | $54.60K | 83,267 |
| Bradley Saenger Chief Financial Officer | Jan 6, 2020 | Award | +493 | $1.02 | $503 | 1,397 |
| Seth Lederman Chief Executive Officer, Director | Dec 3, 2019 | Buy | +20,000 | $1.16 | $23.20K | 23,267 |
| Gregory M. Sullivan Chief Medical Officer | Jul 31, 2019 | Award | +1,142 | $11.82 | $13.50K | 1,405 |
| Bradley Saenger Chief Financial Officer | Jul 31, 2019 | Award | +815 | $11.82 | $9.63K | 904 |
| Seth Lederman Chief Executive Officer, Director | Mar 29, 2019 | Buy | +5,000 | $2.49 | $12.45K | 32,670 |
| Seth Lederman Chief Executive Officer, Director | Mar 26, 2019 | Buy | +25,000 | $2.38 | $59.50K | 27,670 |
| Gregory M. Sullivan Chief Medical Officer | Feb 17, 2019 | Award | +59 | $17.85 | $1.05K | 1,405 |
| Bradley Saenger Chief Financial Officer | Feb 17, 2019 | Award | +59 | $17.85 | $1.05K | 904 |
| Seth Lederman Chief Executive Officer, Director | Jun 29, 2018 | Buy | +500 | $4.64 | $2.32K | 17,666 |
| Seth Lederman Chief Executive Officer, Director | Jun 28, 2018 | Buy | +500 | $4.58 | $2.29K | 17,166 |
| Seth Lederman Chief Executive Officer, Director | Jun 27, 2018 | Buy | +500 | $4.55 | $2.28K | 16,666 |
| Ernest Mario Director | Jun 25, 2018 | Buy | +16,500 | $4.48 | $73.92K | 50,000 |
| Gregory M. Sullivan Chief Medical Officer | Jun 14, 2018 | Buy | +10,000 | $3.97 | $39.70K | 20,482 |
| Bradley Saenger Chief Financial Officer | Jun 14, 2018 | Buy | +300 | $4.10 | $1.23K | 3,079 |
| Jessica Edgar Morris Chief Operating Officer | Jun 14, 2018 | Buy | +300 | $4.19 | $1.26K | 1,638 |
| Seth Lederman Chief Executive Officer, Director | Jun 12, 2018 | Buy | +2,000 | $4.37 | $8.74K | 20,463 |
| Seth Lederman Chief Executive Officer, Director | Jun 12, 2018 | Buy | +1,000 | $4.37 | $4.37K | 16,166 |
| John B. Rhodes Director | Jun 1, 2018 | Buy | +7,500 | $3.33 | $24.98K | 23,470 |
| Seth Lederman Chief Executive Officer, Director | May 25, 2018 | Buy | +4,000 | $3.17 | $12.68K | 26,700 |
| Charles E. Mather Iv Director | Feb 27, 2018 | Option exercise | +750 | – | – | 12,580 |
| Ernest Mario Director | Feb 9, 2018 | Gift | +10,000 | – | – | 33,500 |
| Ernest Mario Director | Feb 9, 2018 | Gift | −10,000 | – | – | 0 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.